PROMISING CLINICAL DATA FROM DOSE ESCALATION IN A PHASE IB/II ONGOING STUDY OF MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN FOR RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN’S LYMPHOMA

Journal article

Peer reviewed

C Diefenbach, E Budde, J Chavez, I. S Lossos, A Mehta, K Dorritie, M Kamdar, R Negricea, S Pham, M Hristopoulos, …

Hematological oncology, Vol.39(S2)

2021-06

Metrics

7 Record Views

Title: PROMISING CLINICAL DATA FROM DOSE ESCALATION IN A PHASE IB/II ONGOING STUDY OF MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN FOR RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN’S LYMPHOMA
Creators: C Diefenbach - NYU Langone Health
E Budde - City Of Hope National Medical Center
J Chavez - Moffitt Cancer Center
I. S Lossos - University of Miami Health System
A Mehta - University of Alabama at Birmingham
K Dorritie - UPMC Hillman Cancer Center
M Kamdar - University of Colorado Cancer Center
R Negricea - Roche
S Pham - Roche
M Hristopoulos - Genentech
Ling-Y Huw - Genentech
C. O Hear - Genentech
Y Oki - Genentech
I To - Genentech
N Ghosh - Levine Cancer Institute
Publication Details: Hematological oncology, Vol.39(S2)
Academic Unit: Human Resources; UMMG Dept of Surgery - Div of Surgical Oncology; Benefits - Other; UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031713632202976